We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

XEL:NASDAQXcel Energy Inc. Analysis

Data as of 2026-03-10 - not real-time

$82.10

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Xcel Energy (XEL) is trading at $82.10, comfortably above its 20‑day ($81.49), 50‑day ($77.66) and 200‑day ($75.18) simple moving averages, confirming a bullish price trend despite a bearish MACD histogram (-0.19) and a decreasing volume pattern. The RSI sits at 59, indicating the stock is not yet overbought, while the ultra‑low beta of 0.20 underscores its defensive nature relative to the market. Valuation metrics are mixed: a trailing P/E of 24 exceeds the industry average of 20.8, yet the forward P/E of 18 suggests earnings are expected to accelerate, and analysts’ consensus price targets (~$89‑$90) imply modest upside (~8%).
Fundamentally, XEL posted 14% revenue growth and a solid operating margin of 16.7%, but its balance sheet is strained with a debt‑to‑equity ratio of 152.8 and negative free cash flow of $7.0 B, raising concerns about long‑term cash generation. The dividend remains attractive at 2.89% with a 66.7% payout, and the board just raised the quarterly payout to $0.5925 per share. Recent UBS coverage upgraded the stock from Neutral to Buy, reinforcing analyst optimism despite the high leverage and a DCF‑derived fair value of $56.98 that flags potential overvaluation.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price nearing resistance at $84.23
  • Bearish MACD histogram
  • Decreasing volume trend

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • UBS upgrade to Buy
  • 14% revenue growth and improving forward earnings
  • Strong dividend yield with recent payout increase

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Regulated utility business providing stable cash flows
  • High debt‑to‑equity ratio and negative free cash flow
  • Low beta and defensive sector positioning

Key Metrics & Analysis

Financial Health

Revenue Growth14.10%
Profit Margin13.76%
P/E Ratio24.0
ROE9.36%
ROA2.39%
Debt/Equity152.83
P/B Ratio2.2
Op. Cash Flow$4.1B
Free Cash Flow$-7018250240
Industry P/E20.8

Technical Analysis

TrendBullish
RSI59.2
Support$74.94
Resistance$84.23
MA 20$81.49
MA 50$77.66
MA 200$75.18
MACDBearish
VolumeDecreasing
Fear & Greed Index79.25

Valuation

Fair Value$56.98
Target Price$88.94
Upside/Downside8.33%
GradeOvervalued
TypeBlend
Dividend Yield2.89%

Risk Assessment

Beta0.20
Volatility17.50%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.